Found: 2
Select item for more details and to access through your institution.
Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six‐month, randomized, placebo‐controlled, double‐blind clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1487, doi. 10.1111/dom.13655
- By:
- Publication type:
- Article
Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article